CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $61,548 | -37.0% | 26,760 | 0.0% | 0.01% | -44.4% |
Q2 2023 | $97,674 | -70.7% | 26,760 | -71.3% | 0.01% | -65.4% |
Q1 2023 | $333,070 | +25.3% | 93,297 | 0.0% | 0.03% | +52.9% |
Q4 2022 | $265,896 | +27.8% | 93,297 | 0.0% | 0.02% | +30.8% |
Q3 2022 | $208,000 | -16.8% | 93,297 | -7.1% | 0.01% | 0.0% |
Q2 2022 | $250,000 | -97.7% | 100,464 | -95.5% | 0.01% | -97.3% |
Q1 2022 | $10,952,000 | -61.9% | 2,244,359 | -11.6% | 0.48% | -52.0% |
Q4 2021 | $28,724,000 | -23.3% | 2,539,700 | -1.2% | 1.01% | -14.4% |
Q3 2021 | $37,461,000 | +20.1% | 2,571,082 | -4.0% | 1.18% | +33.3% |
Q2 2021 | $31,195,000 | -5.4% | 2,677,666 | -1.0% | 0.89% | -8.1% |
Q1 2021 | $32,989,000 | +5.2% | 2,703,983 | +7.9% | 0.96% | -0.8% |
Q4 2020 | $31,360,000 | -11.0% | 2,506,772 | +7.0% | 0.97% | -9.8% |
Q3 2020 | $35,250,000 | -38.2% | 2,342,216 | +0.7% | 1.08% | -37.3% |
Q2 2020 | $56,995,000 | +60.4% | 2,325,388 | -7.1% | 1.72% | +29.2% |
Q1 2020 | $35,529,000 | +59.3% | 2,503,840 | +78.2% | 1.33% | +93.7% |
Q4 2019 | $22,303,000 | +92.0% | 1,404,941 | +1.9% | 0.69% | +59.4% |
Q3 2019 | $11,618,000 | -6.2% | 1,378,198 | 0.0% | 0.43% | +12.8% |
Q2 2019 | $12,390,000 | +82.5% | 1,378,198 | +57.0% | 0.38% | +80.2% |
Q1 2019 | $6,788,000 | +64.5% | 878,098 | 0.0% | 0.21% | +66.9% |
Q4 2018 | $4,127,000 | -46.5% | 878,098 | +2.9% | 0.13% | -38.9% |
Q3 2018 | $7,721,000 | +53.7% | 853,098 | +101.4% | 0.21% | +2.5% |
Q2 2018 | $5,024,000 | – | 423,580 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 948,389 | $13,818,000 | 26.68% |
Prosight Management, LP | 655,185 | $9,546,000 | 5.25% |
P.A.W. CAPITAL CORP | 125,000 | $1,821,000 | 1.62% |
Nantahala Capital Management | 2,571,082 | $37,461,000 | 1.18% |
Slate Path Capital LP | 1,483,619 | $21,616,000 | 0.99% |
Robertson Stephens Wealth Management, LLC | 478,500 | $6,971,000 | 0.79% |
SANDERS MORRIS HARRIS LLC | 305,732 | $4,103,000 | 0.75% |
APOGEM CAPITAL LLC | 51,766 | $754,000 | 0.48% |
683 Capital Management, LLC | 743,772 | $10,837,000 | 0.42% |
Bleichroeder LP | 175,000 | $2,550,000 | 0.41% |